Glaxo sells 2 million alli kits - projects $1.5 billion in annual sales

Associated Press reports today "Drugmaker says 2 million starter kits of weight loss pill sold since June". We here at the PAL Blog have been reporting on alli's brisk sales ever since we have GlaxoSmithKline one of our Bitter Pill Awards back in May, th

PAL Member Medicare Rights Center calls for "Medicare-operated drug plan"

Below is a press release issued today by the Medicare Rights Center and Consumers Union, the nonprofit publisher of Consumer Reports. The press release calls for the creation of a Medicare-operated prescription drug plan, alongside the plans run by priva

NY Times article on Sleep Drugs -- Wildly Popular, Only Mildly Effective

Stephanie Saul at the New York Times did a great article today, "Sleep Drugs Found Only Mildly Effective, but Wildly Popular" The article dispels the myths concerning the effectiveness of the expensive brand-name prescription sleep aids whose television a

A conversation with Renee Rulin, medical director at Commonwealth Care Alliance

Renee Rulin, Medical Director at Commonwealth Care Alliance and a clinical professor of family medicine at Brown University, talked to PostScript about the way pharmaceutical companies affected her days in private practice, and the work CCA is doing now.

PAL & 26 organizations submit comments to FDA on drug ad study

FOR IMMEDIATE RELEASE October 19, 2007 Contact: Mark Snyder (617) 275-2931, msnyder@communitycatalyst.org Prescription Access Litigation and 26 Consumer Groups Issue Statement on Proposed FDA Study of Prescription Drug Ads Criticizes Lack of FDA enforceme

Boston Channel report on Lipitor switches misses the point

In the past several months, WCVB in Boston has run two reports on insurers giving financial incentives to doctors to switch patients off the expensive brand-name cholesterol drug Lipitor (made by Pfizer [NYSE:PFE] and on to a cheaper drug, either generi

$50 million/year spent marketing Cough & Cold Meds for Kids Despite Evidence of Risks

Today the FDA is holding a hearing on over-the-counter cough medicines marketed for use in children under 6. Our colleagues at the Prescription Project have issued a new report, Risk With No Benefit: The Marketing of Over-the-Counter Cough and Cold Medic

DIDA's Big Idea: Disclosure

The Center for Knowledge Management at the University of California San Francisco wants to expand its Drug Industry Document Archive, an online storehouse for pharmaceutical industry documents.  When the Prescription Project, which supports increased disc

Trailer for "Money Talks" Documentary - featuring PAL's Director

Below is a new trailer for the documentary, Money Talks. The documentary is a companion to the independent feature film, Side Effects, which stars Katherine Heigl, of Grey's Anatomy fame. "This 50-minute documentary was created to give an in-depth, ac